<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ETODOLAC</span><br/>(e-to'do-lac)<br/><span class="topboxtradename">Lodine, </span><span class="topboxtradename">Lodine XL<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">analgesic, nonsteroidal antiinflammatory agent, nsaid</span>; <span class="classification">antipyretic</span><br/><b>Prototype: </b>Ibuprofen<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>400 mg tablets; 200 mg, 300 mg capsules; 400 mg, 600 mg sustained release tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Exact mechanism of action is unknown but may inhibit cyclooxygenase activity and prostaglandin synthesis. <small>NSAIDS</small> may also suppress production of rheumatoid factor.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Produces analgesic, antiinflammatory effects of a <small>NSAID</small>.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Osteoarthritis and acute pain, rheumatoid arthritis.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Temporal arteritis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to <small>NSAIDS</small> and in GI ulceration or inflammation; lactation. Safety and efficacy in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Renal impairment, liver function impairment, patients over 65 y, and pregnancy (category C).</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Acute Pain</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 200400 mg q68h prn<br/><br/><span class="indicationtitle">Osteoarthritis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 6001200 mg/d in 24 divided doses, (max: 1200 mg/d or 20 mg/kg for patients <img src="../images/special/lesserorequal.gif"/>60
               kg; Lodine XL 4001000 mg once daily)<br/><br/><span class="indicationtitle">Rheumatoid Arthritis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 500 mg b.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with food or antacid to reduce risk of GI ulceration.</li>
<li>Ensure that sustained release form of drug is not chewed or crushed. It must be swallowed whole.</li>
<li>Store at 15°25° C (59°77° F); tablets and capsules in bottles; sustained release capsules
            in unit-dose packages. Protect all forms from moisture.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CV:</span> Fluid retention, edema. <span class="typehead">CNS:</span> Dizziness, headache, drowsiness, insomnia. <span class="typehead">GI:</span> <span class="speceff-common">Dyspepsia, nausea, vomiting, diarrhea,</span> indigestion, heartburn, abdominal pain, constipation, flatulence, gastritis, melena, peptic ulcer, GI bleeding. <span class="typehead">Hematologic:</span> Thrombocytopenia, increased bleeding time. <span class="typehead">Skin:</span> Rash, pruritus. <span class="typehead">Urogenital:</span> Urinary frequency. <span class="typehead">Metabolic:</span>  Hepatotoxicity. <span class="typehead">Special Senses:</span> Blurred vision; tinnitus. <span class="typehead">Respiratory:</span> Asthma. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>May cause a false-positive <span class="alt">urinary bilirubin</span> test and a false-positive <span class="alt">ketone</span> test done with the dipstick method. May cause a small decrease (1 to 2 mg/dL) in <span class="alt">serum uric acid</span> levels.
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May reduce the effects of <b>diuretics</b> and the antihypertensive effects of <b>beta blockers</b> and other <span class="classification">antihypertensive medications</span>. May increase <b>digoxin</b> and <b>lithium</b> levels and nephrotoxicity due to <b>cyclosporine.</b> <span class="typehead">Herbal:</span> <b>Feverfew,</b> <b>garlic,</b> <b>ginger,</b> <b>ginkgo</b> may increase bleeding. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 30 min. <span class="typehead">Peak:</span> 12 h. <span class="typehead">Duration:</span> 412 h. <span class="typehead">Distribution:</span> Widely distributed; 99% protein bound; not known if crosses placenta or if distributed into breast milk. <span class="typehead">Metabolism:</span> Extensively metabolized in liver. <span class="typehead">Elimination:</span> 72% excreted in urine, 16% in feces. <span class="typehead">Half-Life:</span> 67 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Assess for signs of GI ulceration and bleeding. Risk factors include high doses of etodolac, history of peptic ulcer disease,
            alcohol use, smoking, and concomitant use of aspirin.
         </li>
<li>Assess carefully for fluid retention by monitoring weight and observing for edema in patients with a history of CHF.</li>
<li>Monitor for decreased BP control in hypertensive patients.</li>
<li>Lab tests: Periodic CBC and kidney and liver function.</li>
<li>Monitor for drug toxicity when used concurrently with either digoxin or lithium.</li>
<li>Monitor for rhinitis, urticaria, or other signs of allergic reactions. Discontinue drug and notify physician when present.</li>
<li>Monitor carefully increases in etodolac dosage with older adult patients; adverse effects are more pronounced.</li>
<li>Monitor for headaches, especially at high doses. Discontinuation of therapy may be indicated.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Learn S&amp;S of GI ulceration. Stop medication in presence of bleeding and contact the physician immediately.</li>
<li>Do not take aspirin, which may potentiate ulcerogenic effects.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>